Navigation Links
Springer signs publishing agreement with ISOBM
Date:1/7/2010

Springer, a leading publisher in the fields of science, technology and medicine, has signed an agreement with the International Society of Oncology and BioMarkers (ISOBM) to co-publish the journal Tumor Biology starting in January 2010. Tumor Biology was founded by the ISOBM in 1980 as Oncodevelopmental Biology and Medicine. It will be published at Springer six times a year electronically and in print.

Tumor Biology publishes original research, mini-reviews and commentaries on translational cancer research. The journal places special emphasis on articles covering all aspects of tumor markers and tumor targeting, but studies in other areas of clinical and translational cancer research are included as well. Following a multidisciplinary approach, Tumor Biology provides an important platform for cell and molecular biologists, developmental biologists, pathologists, clinical oncologists and any researcher involved in the study of tumors. The editor-in-chief is Professor Torgny Stigbrand from Ume University, Ume, Sweden.

Dr. Petra Stieber, President of ISOBM, said, "Tumor biology is the major target for research to elucidate mechanisms behind tumor formation and may contribute to minimize consequences of malignant diseases for patients. It is a true pleasure to work with a worldwide-recognized publisher and we look forward to a long and fruitful collaboration with Springer."

Peter Butler, Editorial Director of Biomedicine and Life Sciences at Springer, said, "We are delighted to be able to join forces with the ISOBM and Professor Stigbrand. We look forward to developing the content of Tumor Biology further and to increasing the journal's visibility through the global reach of SpringerLink."


'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Page: 1

Related biology news :

1. International Biometric Society co-publishes journal with Springer
2. Springer signs agreement with British Society of Research on Ageing
3. Biomedical Engineering Societys new journal to be published by Springer
4. Editor of Springer classic human genetics reference receives prize
5. Springer signs co-publishing agreement with the Royal Swedish Academy of Sciences
6. Springer and the American College of Medical Toxicology to work together
7. Springer launches new journal Food Digestion
8. Springer to publish Symbiosis
9. Springer to collaborate with the Human Genome Organization
10. Springer launches SpringerImages
11. Springer Series editor John Smol receives two prestigious biology awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):
(Date:5/20/2016)... ... , ... The leading Regenerative Veterinary Medicine Company, VetStem Biopharma ., is ... 100 of their own patients with the VetStem Cell Therapy. Each of these veterinarians ... their patients. , The veterinarians are Dr Ross Rich former owner of Cave ...
(Date:5/19/2016)... Virginia (PRWEB) , ... May 19, 2016 , ... Anton ... new 30,000 square foot office building is complete. The new structure adds a third ... 2011, Anton Paar USA purchased 2.4 acres of land, along with office ...
(Date:5/19/2016)... DIEGO , May 19, 2016 ... (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today ... creating the first cord blood based cancer immunotherapeutic ... provisional patent application, Regen described a generation of ... was potentiated by gene silencing.  The product in ...
(Date:5/18/2016)... YORK , May 18, 2016 ... but it does not mean that there are no opportunities ... Threshold Pharmaceuticals Inc. (NASDAQ: THLD ), Seattle Genetics ... CHMA ), and Ophthotech Corp. (NASDAQ: OPHT ... trading alerts at: http://www.activewallst.com/ ...
Breaking Biology Technology: